Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to study the efficacy of a daily dose of 200 mg AZD9056 in patients with active CD affecting ileum and/or colon by assessment of the change in CDAI from baseline after 28 days treatment.
Critère d'inclusion
- Crohn’s Disease